The use of celecoxib for reduction of pain after subpectoral breast augmentation
被引:42
作者:
Parsa, AA
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USAUniv Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USA
Parsa, AA
[1
]
Soon, CWM
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USAUniv Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USA
Soon, CWM
[1
]
Parsa, FD
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USAUniv Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USA
Parsa, FD
[1
]
机构:
[1] Univ Hawaii, John A Burns Sch Med, Dept Surg, Div Plast Surg, Honolulu, HI 96813 USA
breast implants;
Celebrex;
celecoxib;
pain after breast surgery;
pain and Subpectoral breast augmentation;
D O I:
10.1007/s00266-005-0032-1
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
A study was conducted to determine whether a single 400-mg dose of oral celecoxib administered 30 min before surgery reduces the opioid requirement for patients undergoing aesthetic subpectoral breast augmentation. A total of 695 patients undergoing breast augmentation were randomly selected into either a placebo or a treatment group. The findings showed that patients who received 400 mg of celecoxib 30 min before surgery required significantly fewer opioid analgesics after the operation than those given a placebo (p < 0.001). It also was found that nonsmokers and multiparous women required significantly fewer opioids than smokers and nulliparous women (p < 0.001). On the basis of this prospective study, the authors recommend a single 400-mg dose of celecoxib administered 30 min before surgery to decrease opioid analgesic requirements after subpectoral breast augmentation.